AzTrials
AzTrials

OstomyQoLMioNCT04635215

Observational Study of the Quality of Life of New Ostomates Using SenSura Mio Appliances With BodyFit Technology

An observational study of Ostomy, run by Laboratoires Coloplast S.A.S at 78 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

An ostomy is defined by the connection of a viscera to the skin, outside its natural location, by diversion from the digestive or urinary tract. The bodily injury, i.e. the creation of a stoma, has familiar, social and professional consequences. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ostomy
What is being tested?
Sensura Mio Bodyfit technology ostomy pouches
Type of treatment
Medical device
How many people
195 participants
Where
78 sitesFrance
Study dates
27 Feb 2019to 31 Mar 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: The QoL Mio study population will consist of adults with recent ostomies (< 1 month after stoma creation) for whom healthcare professionals have recommended the use of SenSura Mio ostomy care devices as part of care routines.

Who may be able to join

  • Male or female aged over 18 year old
  • Subject who signed the consent form
  • Subject affiliated to a social security scheme or entitled to a social security benefit
  • Subject with an ostomy less than one month old, with an expected stoma duration > 3 months
  • Subject presenting an enterostomy with liquid effluents (right colostomy, ileostomy, jejunostomy) or a urostomy, user of a high flow or drainable pouch (Uro)
  • Subjects for which the healthcare professional decided to use the SenSura Mio Technology BodyFit™ as the first permanent ostomy appliance after surgery as part of the care routines
  • Subject educated in ostomy care and who manages it himself in an autonomous or assisted manner.

Who cannot join

  • Vulnerable subject with regard to the regulations in force
  • Pregnant, parturient or breastfeeding woman ;
  • Subject deprived of liberty by judicial, medical or administrative decision;
  • Minor subject;
  • Subject legally protected or unable to express consent;
  • Subject not affiliated or not benefiting from a social security system;
Show all 11Show fewer
  • Subject falling into several of the above categories;
  • Subject who refused to participate in the study; and
  • Subject participating in other research or clinical studies
  • Subject for which stoma closure is scheduled before the end of the study
  • A subject who, according to the investigator, has cognitive problems that prevent him or her from answering a questionnaire or for whom evaluation could be problematic.

Trial locations and contacts

78 sites in 1 country.

78 sites in 1 country

France78 sites
  • Centre Hospitalier Du Pays D'Aix

    Aix-en-Provence, 13616

  • Hotel Dieu

    Angers, 49933

  • Centre Hospitalier d'Arras

    Arras, 62022

  • Hopital de Mercy

    Ars-Laquenexy, 57530

  • Centre Hospitalier Henri Mondor

    Aurillac, 15002

  • Ch Henri Duffaut

    Avignon, 84902

  • Clinique Belharra

    Bayonne, 64100

  • Centre Hospitalier de Beauvais

    Beauvais, 60021

  • Hopital Jean Minjoz

    Besançon, 25030

  • Hopital La Cavale Blanche

    Brest, 29609

  • Hopital Cote de Nacre

    Caen, 14033

  • Centre Hospitalier de Douai

    Cambrai, 59187

  • Hopital Du Pays D Autan

    Castres, 81108

  • Hopital Manchester

    Charleville-Mézières, 8011

  • Centre Hospitalier General

    Châteauroux, 36019

  • Centre Hospitalier Du Cotentin Site de Cherbourg

    Cherbourg Octeville, 50102

  • Hopital Beaujon

    Clichy, 92118

  • Hopital Sud Francilien

    Corbeil-Essonnes, 91106

  • Centre Georges François Leclerc

    Dijon, 21079

  • Clinique Claude Bernard

    Ermont, 95120

  • Cabinet infirmier

    Étrelles, 35370

  • Centre Hospitalier Intercommunal Eure Seine

    Évreux, 27015

  • Cabinet Infirmier

    Flins-sur-Seine, 78410

  • Hopital Nord Ouest

    Gleizé, 69400

  • Centre Hospitalier de Gonesse

    Gonesse, 95500

  • Hopital Saint Louis

    La Rochelle, 17000

  • Hopital La Source

    La Source, 45100

  • Hopital Prive de L Estuaire

    Le Havre, 76620

  • Pole Sante Sud

    Le Mans, 72016

  • Centre Hospitalier Du Dr Schaffner

    Lens, 62307

  • Hopital Robert Boulin

    Libourne, 33505

  • Hopital Dupuytren

    Limoges, 87042

  • Hopital Saint Philibert

    Lomme, 59160

  • Polyclinique Du Val de Saone

    Mâcon, 71031

  • Hopital Nord

    Marseille, 13015

  • Hopital Alphonse Laverand

    Marseille, 13384

  • Hopital de La Conception

    Marseille, 13385

  • Centre Hospitalier Annecy Genevois Site Annecy

    Metz-Tessy, 74370

  • Hopital Lapeyronie

    Montpellier, 34295

  • Clinique St Augustin

    Nantes, 44046

  • CHU Hôtel-Dieu

    Nantes, 44093

  • Hopital Caremeau

    Nîmes, 30029

  • Centre Hospitalier Georges Renon

    Niort, 79021

  • Centre Hospitalier de Guingamp

    Pabu, 22200

  • Hopital Saint Louis

    Paris, 75475

  • Hopital Saint Antoine

    Paris, 75572

  • Hopital Saint Antoine

    Paris, 75573

  • Hopital Cochin

    Paris, 75679

  • Hopital Bichat Claude Bernard

    Paris, 75877

  • Hopital Europeen Georges Pompidou

    Paris, 75908

  • Hopital Tenon

    Paris, 75970

  • Centre Hospitalier Francois Mitterand

    Pau, 64000

  • Hopital Saint Jean

    Perpignan, 66046

  • Clinique Mutualiste de Pessac

    Pessac, 33605

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495

  • Centre Hospitalier Universitaire La Miletrie

    Poitiers, 86021

  • Hopital Pontchaillou

    Rennes, 35033

  • Centre Hospitalier de Rochefort

    Rochefort, 17301

  • Hopital Charles Nicolle

    Rouen, 76031

  • Hopital Yves Le Foll

    Saint-Brieuc, 22027

  • Centre Hospitalier St Charles

    Saint-Dié, 88187

  • Cabinet infirmier

    Saint-Hilaire-de-Riez, 85270

  • Hopital Nord

    Saint-Priest-en-Jarez, 42277

  • Les Hopitaux Du Mont Blanc

    Sallanches, 74703

  • Centre Hospitalier de Salon de Provence

    Salon-de-Provence, 13658

  • Centre Hospitalier de Seclin/Carvin

    Seclin, 59471

  • Hopital Civil

    Strasbourg, 67091

  • Hopital Hautepierre

    Strasbourg, 67098

  • Centre Hospitalier de La Gespe

    Tarbes, 65013

  • Hopitaux Du Leman Site Thonon

    Thonon-les-Bains, 74203

  • Hopital Sainte Musse

    Toulon, 83056

  • Hopital Rangueil

    Toulouse, 31059

  • Hopital Des Hauts Clos

    Troyes, 10003

  • Centre Hospitalier General

    Valence, 26953

  • Polyclinique Vauban

    Valenciennes, 59300

  • Centre Hospitalier de Valenciennes

    Valenciennes, 59322

  • Hopitaux de Brabois

    Vandœuvre-lès-Nancy, 54511

  • Hopital Robert Schuman

    Vantoux, 57070

Other trials in France

About this study

Official title: Observational Study of the Quality of Life of Patients With New Stoma Formation and Users of a Stoma Appliance From the SenSura Mio Range With Bodyfit® Technology

An ostomy is defined by the connection of a viscera to the skin, outside its natural location, by diversion from the digestive or urinary tract. The bodily injury, i.e. the creation of a stoma, has familiar, social and professional consequences. Personalized care, with the help of an ostomy nurse, is essential to accompany the ostomy patient in the changes of his or her life habits. In addition, the progress made in the various appliances, pouching and irrigation systems, contribute to improving the quality of life of these people.

In this context of adapted support, COLOPLAST has developed a range of ostomy pouches, the SenSura Mio BodyFit® technology range, for digestive or urinary stomas. The diversity of the devices makes it possible to find the most suitable combination to adapt to the morphology thanks to an elastic adhesive for a secure fit to individual body shape, and the textile materials used make it possible to optimize wearing comfort.

The aim of this study is to evaluate the quality of life of patients with recent ostomies with one of COLOPLAST's SenSura Mio devices at three months after discharge from the hospital. The condition of the skin around the stoma and the level of satisfaction of the patients will also be evaluated. Finally, the results obtained aim to identify factors predictive of a better quality of life in order to improve management.

Read the detailed description

Today, there are about 80,000 people with ostomies in France and 19,000 ostomies are created each year.

An ostomy is defined by a viscera reaching the skin, outside its natural location, by diversion of the digestive (enterostomy) or urinary (ureterostomy) tract. Digestive ostomies are temporary or permanent palliative surgeries that consist of connecting a segment of the healthy digestive tract to the surface of the skin, either downstream or upstream of a lesion. There are several reasons for this type of stoma: following colorectal cancer or IBD (chronic inflammatory bowel disease), or to decompress and drain the digestive tract in occlusion, or to protect a digestive anastomosis by temporarily diverting the intestinal flow. Urinary ostomies are usually performed following bladder cancer or neurogenic bladder that has resulted in the removal of the bladderr. The urinary tract is then diverted to allow the evacuation of urine into an artificial pouch.

The bodily injury, the creation of a stoma, can have serious familiar, social and professional repercussions. An early follow-up from the preoperative phase and long-term technical and psychological support promote an adaptation of quality. Helping the patient to live well with his disability is a complex task that mobilizes the skills of a multidisciplinary team of caregivers. Mastery of surgical techniques for the creation of ostomies and close collaboration between the surgeon and the stoma therapist are essential for the personalized care of ostomy patients.

Advances in various devices, bag systems and irrigation systems are concrete means that contribute greatly to improving the patient's quality of life. In this context of technological advances, COLOPLAST has developed a range of devices for incontinent digestive and urinary stomas, SenSura Mio Technology BodyFit®. This range of pouches adapts to peristomal morphology and body movements due to an elastic adhesive for a secure fit to individual body shapes. In addition, the pouches are designed to remain discreet and maximize wearing comfort due to a neutral-grey color water-repellent textile material, invisible even under white clothing, and a full-circle prefilter to differ filter saturation for proven reduction of ballooning.

The objective of this study is to evaluate the use of SenSura Mio products in real-life conditions in patients with recent ostomies. For this purpose, we will use the Stoma-QoL specific quality of life scale, as well as the Peristomal Skin Condition Rating Scale (DET Score).

The Stoma-QoL tool was developed and validated specifically for ostomy patients in 2005 at the initiative of COLOPLAST and in close collaboration with international experts, with the aim of evaluating the impact of ostomy related concerns on the quality of life of ostomy patients on the one hand, and improving and facilitating their follow-up on the other hand. Potential items were formulated based on the results of a series of semi-structured interviews conducted with 169 adult subjects who had ostomies for a long time. The process resulted in a preliminary version of 37 items, administered repeatedly to 182 subjects with an ileostomy or colostomy. A psychometric selection of the items was performed using a Rasch model. The Stoma-QOL questionnaire has in its most refined version 20 questions covering 4 domains, not scored independently: sleep, intimate relationships, relationships with family and close friends, and social relationships with other people. This 20-item version has been validated internationally in ileo- or colostomized patients. On average, the value of the overall Stoma-QoL score was 58.5 with the lowest mean value (53.8) observed in France and the highest mean value (62.6) in Denmark. Stoma-QoL can be offered to ostomy patients who have already lived at least 1 month with their stoma and appliance.

The DET Score -also known as the Ostomy Skin Tool- is a measurement tool for assessing the extent and severity of peristomal skin problems. It was developed by Martins et al in 2008, at the initiative of COLOPLAST and in close collaboration with international experts, with the intention of improving the monitoring of peristomal skin conditions in ostomy patients and optimizing communication between healthcare professionals. The DET Score is divided into three areas: Discoloration (D), Erosion (E) and Tissue Proliferation (T). For each area, a maximum of 5 points can be awarded, 3 for the affected area and 2 for severity. The scores for each domain should be based solely on observations of each subject's skin, not on past experience. Photographs of problem skin are included in this rating scale and can be used as a guide for scoring severity. Once the score for each domain has been assessed, a total score is calculated by adding the numbers. A score of 0 represents normal skin while a score of 15 represents maximum skin severity around the stoma. The DET Score was validated in 2011 18: it is now widely used and has been translated into several languages. Skin problems are considered mild if DET Score ≤ 4; moderate if DET Score < 7; severe if DET Score ≥ 7. The mean value observed in an international study of more than 3,000 ostomy patients was 2.5 (± 2.8).

The objectives of the present study are multiple: to evaluate the quality of life of patients with recent ostomies using SenSura Mio appliances during the first three months following hospital discharge, to evaluate the condition of the peristomal skin during this same period and to look for factors predictive of a better quality of life. The data collected in this study will help to better document the factors influencing the quality of life of French patients with recent ostomies and the value of using the new SenSura Mio appliances. This study will also provide a better understanding of the incidence of skin problems in the early follow-up phase (first three months) and the main corrective actions taken by the ostomy nurses.

The QoL Mio study population will be composed of adults with recent ostomies (stoma preparation < 1 month), with liquid effluent (right colostomy, ileostomy, jejunostomy or urostomy), for whom healthcare professionals have recommended the use of SenSura Mio devices for ostomy care as part of the routine care. Because liquid effluents can seep under the adhesive on the skin, this population (ostomy with liquid effluents) has a higher risk of peristomal skin damage with irritant dermatitis by contact with corrosive effluents. The BodyFit technology (conforms to folds and irregularities of the skin) of SenSura Mio devices appears to be particularly suitable in this population to preserve the integrity of the peristomal skin.

Conditions
Ostomy
Being tested
Sensura Mio Bodyfit technology ostomy pouches

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sensura Mio Bodyfit technology ostomy pouchesDevice

    The use of medical devices, the ostomy pouches from Sensura Mio Bodyfit technology range, will be studied from inclusion visit (less than one month after the beginning of use) and during 3 months.

Study groups in NCT04635215
Study groupRoleWhat they receive
ParticipantsThere are not multiple groups in this study
Receives: Device: Sensura Mio Bodyfit technology ostomy pouches

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stoma QoL score at 3 months

    The Stoma-QOL questionnaire has 20 questions covering 4 domains,: sleep, intimate relationships, relationships with family and close friends, and social relationships with other people.

    For each question, the answer ranges from 1 (always) to 4 (never). The points obtained for each of the 20 questions are added together to obtain an overall score. This raw summary score per patient in the 20-80 range will be converted into a final "0-100 score" where 0 indicates the worst Quality of Life and 100 the best Quality of Life. A table is available for converting raw scores into final scores.

    Measured: The primary outcome will be measured at 3 months

Secondary outcomes (3)
  1. Stoma QoL score at 1 and 2 months

    The Stoma-QOL questionnaire has 20 questions covering 4 domains,: sleep, intimate relationships, relationships with family and close friends, and social relationships with other people.

    For each question, the answer ranges from 1 (always) to 4 (never). The points obtained for each of the 20 questions are added together to obtain an overall score. This raw summary score per patient in the 20-80 range will be converted into a final "0-100 score" where 0 indicates the worst Quality of Life and 100 the best Quality of Life. A table is available for converting raw scores into final scores.

    Measured: At 1 and 2 months

  2. DET Score

    The DET Score is divided into three areas: Discoloration (D), Erosion (E) and Tissue Proliferation (T). For each area, a maximum of 5 points can be awarded, 3 for the affected area and 2 for severity. The scores for each domain should be based solely on observations of each subject's skin, not on past experience. Photographs of problem skin are included in this rating scale and can be used as a guide for scoring severity. Once the score for each domain has been assessed, a total score is calculated by adding the numbers. A score of 0 represents normal skin while a score of 15 represents maximum skin severity around the stoma.

    Measured: At 1, 2 and 3 months

  3. Patient satisfaction

    Patient satisfaction will be evaluated using a visual scale with a score comprised between 0 and 10. A score of 0 (lower value) means insatisfaction and a score of 10 (maximum) means total satisfaction.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2020
  2. Study start27 Feb 2019
  3. Primary completion31 Mar 2021
  4. Study completion31 Mar 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
195 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04635215
Sponsor's protocol ID
2018-A03232-53
Other IDs
2018-A03232-53
Acronym
QoLMio
Status last verified
Jul 2021
First submitted
13 Nov 2020
Last updated
28 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Ostomy, run by Laboratoires Coloplast S.A.S at 78 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 78 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stoma QoL score at 3 months (time frame: The primary outcome will be measured at 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in